Articles by Disease (Prostate Cancer)

The Leukocyte Common Antigen-Related Protein LAR: Candidate PTP for Inhibitory Targeting

Journal: Current Topics in Medicinal Chemistry
Volume: 3
Page: 809-819
Author(s): Charles M. LeVea and Robert A. Mooney

Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 77-93
Author(s): C. Cal, H. Garban, A. Jazirehi, C. Yeh, Y. Mizutani and B. Bonavida

Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 95-117
Author(s): S. Shinkaruk, M. Bayle, G. Lain and G. Deleris

New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 119-131
Author(s): Shinji Osada and Shigetoyo Saji

Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 133-138
Author(s): Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia

Glucuronides in Anti-Cancer Therapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 139-150
Author(s): Xi Chen, Bingyuan Wu and Peng George Wang

Unfolding the Pathophysiological Role of Bioactive Lysophospholipids

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3
Page: 23-32
Author(s): Yan Xu, Yi-jin Xiao, Kui Zhu, Linnea M. Baudhuin, Jun Lu, Guiying Hong, Kwan-sik Kim, Kelly L. Cristina, Li Song and Freager S. Williams

‹
1
2
...
1226
1227
1228
1229
1230
1231
1232
...
1252
1253
›